L-Asparaginsyra en es it fr

L-Asparaginsyra Brand names, L-Asparaginsyra Analogs

L-Asparaginsyra Brand Names Mixture

  • No information avaliable

L-Asparaginsyra Chemical_Formula


L-Asparaginsyra RX_link

No information avaliable

L-Asparaginsyra fda sheet

L-Asparaginsyra msds (material safety sheet)


L-Asparaginsyra Synthesis Reference

No information avaliable

L-Asparaginsyra Molecular Weight

133.104 g/mol

L-Asparaginsyra Melting Point

230 oC

L-Asparaginsyra H2O Solubility

4.5 g/l

L-Asparaginsyra State


L-Asparaginsyra LogP

-0.67 +/- 0.36

L-Asparaginsyra Dosage Forms

Capsules and powder

L-Asparaginsyra Indication

There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.

L-Asparaginsyra Pharmacology

L-aspartate is considered a non-essential amino acid, meaning that, under normal physiological conditions, sufficient amounts of the amino acid are synthesized in the body to meet the body's requirements. L-aspartate is formed by the transamination of the Krebs cycle intermediate oxaloacetate. The amino acid serves as a precursor for synthesis of proteins, oligopeptides, purines, pyrimidines, nucleic acids and L-arginine. L-aspartate is a glycogenic amino acid, and it can also promote energy production via its metabolism in the Krebs cycle. These latter activities were the rationale for the claim that supplemental aspartate has an anti-fatigue effect on skeletal muscle, a claim that was never confirmed.

L-Asparaginsyra Absorption

Absorbed from the small intestine by an active transport process

L-Asparaginsyra side effects and Toxicity

Mild gastrointestinal side effects including diarrhea. LD50 (rat) > 5,000 mg/kg.

L-Asparaginsyra Patient Information

No information avaliable

L-Asparaginsyra Organisms Affected

Humans and other mammals